Amgen, Inc. vs Public Storage — how do they compare? Amgen, Inc. trades at $412.21 (market cap $224.14B), while Public Storage trades at $324.41 (market cap $60.71B). The key difference: Amgen, Inc. is far larger — about 3.7× Public Storage's market cap, and Public Storage pays the higher dividend (3.69%). Which is the better fit depends on your goals.
| AMGN | PSA | |
|---|---|---|
Market Cap | $224.14B | $60.71B |
Sector | Health | Real Estate |
52-Week High | $417.20 | $330.47 |
52-Week Low | $271.18 | $258.44 |
Enterprise Value | $267.45B | $74.98B |
Dividend Yield | 2.43% | 3.69% |
Trailing returns across standard periods
Latest headlines on both assets
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →